• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CARDIOVASCULAR SYSTEM CORP TERUMO CDI 500 BLODO PARAMETER MONITOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CARDIOVASCULAR SYSTEM CORP TERUMO CDI 500 BLODO PARAMETER MONITOR Back to Search Results
Model Number 500AHCT
Device Problems Thermal Decomposition of Device (1071); Power Conditioning Problem (1474)
Patient Problem Death (1802)
Event Type  Death  
Event Description
It was reported that during use of the device for a extracorporeal membrane oxygenation (ecmo) procedure, the blood parameter monitor (bpm) appeared burnt.The device was not changed out.Refer to the clinical review for further information.Per the clinical review on(b)(6)2015: a (b)(6) neonatal pt was placed on ecmo shortly after birth for cardiac and respiratory support.According to the perfusionist (ccp), the pt was very sick, and at high risk.During the early hours of the morning, the ccp stated there were three power surges in the intensive care room where the ecmo support was being provided.The first surge did not appear to have any impact on any of the equipment or devices used on this pt.The second power surge caused the bpm display to flash, with lines running through the display and a continuous and muted audible tone was observed coming from the bpm.In a very few seconds the display blanked and there was a "burning smell" that appeared to be coming from the bpm monitor.The ccp very quickly disconnected the bpm power cord from the alternating current (a/c) outlet.In a short time, a third power surge occurred and this surge lead to the stopping of the ecmo perfusion pump (not the manufacturer's device).This halted all cardiac and respiratory support.The pt deteriorated, due to loss of cardiac and respiratory support, and the pt expired.The ccp stated that the loss of the bpm unit played no part in the death of the pt.The sudden loss of the pump, which stopped ecmo support, did have an impact on this very ill pt.The bpm unit was not changed out, as the third power surge (with loss of pump capacity) occurred before a replacement bpm unit was available.The ecmo procedure was not completed as planned, and the pt expired.The bpm issue did not delay the procedure and did not lead to associated blood loss.
 
Manufacturer Narrative
Evaluation is in progress, but not yet concluded.No other manufacturer product were being used per clinical services.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TERUMO CDI 500 BLODO PARAMETER MONITOR
Type of Device
CDI 500
Manufacturer (Section D)
TERUMO CARDIOVASCULAR SYSTEM CORP
ann arbor MI 48103
Manufacturer Contact
jan winder
6200 jackson rd.
ann arbor, MI 48103
7346634145
MDR Report Key4652212
MDR Text Key18091437
Report Number1828100-2015-00265
Device Sequence Number1
Product Code DRY
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K972962
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 03/10/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/01/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number500AHCT
Device Catalogue Number500AHCT
Was Device Available for Evaluation? Yes
Date Returned to Manufacturer03/31/2015
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/10/2015
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Treatment
ECMO PERFUSION PUMP
Patient Outcome(s) Death; Required Intervention;
Patient Age3 DA
-
-